Literature DB >> 18713578

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Dennis Bourdette, Vijayshree Yadav.   

Abstract

Entities:  

Year:  2008        PMID： 18713578     DOI： 10.1007/s11910-008-0064-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  5 in total

Review 1.  B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.

Authors:  Edgar Meinl; Markus Krumbholz; Reinhard Hohlfeld
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

Review 2.  Role of B cells in pathogenesis of multiple sclerosis.

Authors:  Behrouz Nikbin; Mandana Mohyeddin Bonab; Farideh Khosravi; Fatemeh Talebian
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 3.  Rituximab: in rheumatoid arthritis.

Authors:  James E Frampton; Lesley J Scott
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

Review 4.  Rituximab for the treatment of rheumatoid arthritis.

Authors:  Arthur A Schuna
Journal:  Pharmacotherapy       Date:  2007-12       Impact factor: 4.705

5.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Authors:  Chris H Polman; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; J Theodore Phillips; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Martin Toal; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245
  5 in total
  4 in total

1.  Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases.

Authors:  Niayesh Mohebbi; Maryam Taghizadeh-Ghehi; Seyed Mehrdad Savar; Siamak Abdi; Romina Kouhsari; Kheirollah Gholami; Shahriar Nafissi
Journal:  Daru       Date:  2022-09-24       Impact factor: 4.088

2.  Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; B Mark Keegan; Jeffrey L Winters; David Astapenko; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  Neurol Res Int       Date:  2011-09-22

3.  Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhaolan Hu; Yanhui Cui; Xiaoqing Qiao; Xinwen He; Fang Li; Cong Luo; Shuang Wang; Changqi Li; Ruping Dai
Journal:  Front Neurosci       Date:  2018-07-10       Impact factor: 4.677

Review 4.  Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  James L Quinn; Robert C Axtell
Journal:  Int J Mol Sci       Date:  2018-10-19       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.